DrugPatentWatch Database Preview

PROTAMINE SULFATE Drug Profile

  Purchase this report

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Protamine Sulfate patents expire, and what generic alternatives are available?

Protamine Sulfate is a drug marketed by Fresenius Kabi Usa, Lilly, Pharmacia And Upjohn, and West-ward Pharms Int. and is included in five NDAs.

The generic ingredient in PROTAMINE SULFATE is protamine sulfate. There are twelve drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the protamine sulfate profile page.

Summary for PROTAMINE SULFATE

US Patents:	0
Applicants:	4
NDAs:	5
Suppliers / Packagers:	1
Clinical Trials:	5
Formulation / Manufacturing:	see details
DailyMed Link:	PROTAMINE SULFATE at DailyMed

Pharmacology for PROTAMINE SULFATE

Drug Class	Heparin Reversal Agent
Mechanism of Action	Heparin Binding Activity
Physiological Effect	Reversed Anticoagulation Activity

US Patents and Regulatory Information for PROTAMINE SULFATE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Fresenius Kabi Usa	PROTAMINE SULFATE	protamine sulfate	INJECTABLE;INJECTION	089454-001	Apr 7, 1987		RX	No	Yes
Pharmacia And Upjohn	PROTAMINE SULFATE	protamine sulfate	INJECTABLE;INJECTION	007413-002	Aug 2, 1984		DISCN	No	No
Lilly	PROTAMINE SULFATE	protamine sulfate	INJECTABLE;INJECTION	006460-002	Approved Prior to Jan 1, 1982		DISCN	Yes	No
Pharmacia And Upjohn	PROTAMINE SULFATE	protamine sulfate	INJECTABLE;INJECTION	007413-001	Approved Prior to Jan 1, 1982		DISCN	No	No

  Purchase this report

see a sample report or, see our see our flat-rate plans

  Purchase this report

see a sample report or, see our see our flat-rate plans